SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The turnover soared 67.56% to Rs. 2709.44 millions for the December 2024 quarter as compared to Rs. 1616.99 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 188.54% to Rs. 453.04  millions from Rs. 157.01 millions in the previous quarter.Operating profit for the quarter ended December 2024 rose to 688.22 millions as compared to 263.99 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2709.44 1616.99 67.56 6856.73 4676.46 46.62 6875.83 6167.34 11.49
Other Income 21.66 28.70 -24.53 126.41 52.31 141.66 137.86 43.20 219.12
PBIDT 688.22 263.99 160.70 1537.27 727.44 111.33 1214.53 1269.82 -4.35
Interest 6.08 25.56 -76.21 54.75 38.38 42.65 58.94 24.14 144.16
PBDT 682.14 238.43 186.10 1482.52 371.52 299.04 838.05 1245.68 -32.72
Depreciation 56.72 35.03 61.92 174.89 103.31 69.29 146.94 123.42 19.06
PBT 625.42 203.40 207.48 1307.63 268.21 387.54 691.11 1122.26 -38.42
TAX 172.38 46.39 271.59 340.64 152.16 123.87 254.25 288.82 -11.97
Deferred Tax 9.67 6.25 54.72 23.23 16.10 44.29 45.12 25.05 80.12
PAT 453.04 157.01 188.54 966.99 116.05 733.25 436.86 833.44 -47.58
Equity 409.34 368.81 10.99 409.34 368.81 10.99 368.81 364.37 1.22
PBIDTM(%) 25.40 16.33 55.58 22.42 15.56 44.13 17.66 20.59 -14.21

Acutaas Chemicals Share Price

2363.65 42.70 (1.84%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×